Global T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026

Global T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CAR-T
1.4.3 TCR
1.4.4 TIL Therapies
1.5 Market by Application
1.5.1 Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Stomach Cancer
1.5.3 Lung Cancer
1.5.4 Colorectal Cancer
1.5.5 Esophagus Cancer
1.5.6 Pancreatic Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 T-Cell Immunotherapy Market Perspective (2015-2026)
2.2 T-Cell Immunotherapy Growth Trends by Regions
2.2.1 T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 T-Cell Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key T-Cell Immunotherapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top T-Cell Immunotherapy Players by Market Size
3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global T-Cell Immunotherapy Market Concentration Ratio
3.2.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2019
3.3 T-Cell Immunotherapy Key Players Head office and Area Served
3.4 Key Players T-Cell Immunotherapy Product Solution and Service
3.5 Date of Enter into T-Cell Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)
5 T-Cell Immunotherapy Breakdown Data by Application (2015-2026)
5.1 Global T-Cell Immunotherapy Market Size by Application (2015-2020)
5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America T-Cell Immunotherapy Market Size (2015-2020)
6.2 T-Cell Immunotherapy Key Players in North America (2019-2020)
6.3 North America T-Cell Immunotherapy Market Size by Type (2015-2020)
6.4 North America T-Cell Immunotherapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe T-Cell Immunotherapy Market Size (2015-2020)
7.2 T-Cell Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe T-Cell Immunotherapy Market Size by Type (2015-2020)
7.4 Europe T-Cell Immunotherapy Market Size by Application (2015-2020)
8 China
8.1 China T-Cell Immunotherapy Market Size (2015-2020)
8.2 T-Cell Immunotherapy Key Players in China (2019-2020)
8.3 China T-Cell Immunotherapy Market Size by Type (2015-2020)
8.4 China T-Cell Immunotherapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan T-Cell Immunotherapy Market Size (2015-2020)
9.2 T-Cell Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan T-Cell Immunotherapy Market Size by Type (2015-2020)
9.4 Japan T-Cell Immunotherapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia T-Cell Immunotherapy Market Size (2015-2020)
10.2 T-Cell Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2020)
11 India
11.1 India T-Cell Immunotherapy Market Size (2015-2020)
11.2 T-Cell Immunotherapy Key Players in India (2019-2020)
11.3 India T-Cell Immunotherapy Market Size by Type (2015-2020)
11.4 India T-Cell Immunotherapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America T-Cell Immunotherapy Market Size (2015-2020)
12.2 T-Cell Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America T-Cell Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America T-Cell Immunotherapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Adaptimmune
13.1.1 Adaptimmune Company Details
13.1.2 Adaptimmune Business Overview and Its Total Revenue
13.1.3 Adaptimmune T-Cell Immunotherapy Introduction
13.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2015-2020))
13.1.5 Adaptimmune Recent Development
13.2 Altor Bioscience Corporation
13.2.1 Altor Bioscience Corporation Company Details
13.2.2 Altor Bioscience Corporation Business Overview and Its Total Revenue
13.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
13.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2015-2020)
13.2.5 Altor Bioscience Corporation Recent Development
13.3 Cellectis
13.3.1 Cellectis Company Details
13.3.2 Cellectis Business Overview and Its Total Revenue
13.3.3 Cellectis T-Cell Immunotherapy Introduction
13.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2015-2020)
13.3.5 Cellectis Recent Development
13.4 Juno Therapeutics
13.4.1 Juno Therapeutics Company Details
13.4.2 Juno Therapeutics Business Overview and Its Total Revenue
13.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
13.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
13.4.5 Juno Therapeutics Recent Development
13.5 Kite Pharma
13.5.1 Kite Pharma Company Details
13.5.2 Kite Pharma Business Overview and Its Total Revenue
13.5.3 Kite Pharma T-Cell Immunotherapy Introduction
13.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2015-2020)
13.5.5 Kite Pharma Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview and Its Total Revenue
13.6.3 Novartis T-Cell Immunotherapy Introduction
13.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Takara Bio
13.7.1 Takara Bio Company Details
13.7.2 Takara Bio Business Overview and Its Total Revenue
13.7.3 Takara Bio T-Cell Immunotherapy Introduction
13.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2015-2020)
13.7.5 Takara Bio Recent Development
13.8 Unum Therapeutics
13.8.1 Unum Therapeutics Company Details
13.8.2 Unum Therapeutics Business Overview and Its Total Revenue
13.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
13.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020)
13.8.5 Unum Therapeutics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. T-Cell Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by T-Cell Immunotherapy Revenue
Table 3. Ranking of Global Top T-Cell Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CAR-T
Table 6. Key Players of TCR
Table 7. Key Players of TIL Therapies
Table 8. Global T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global T-Cell Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global T-Cell Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global T-Cell Immunotherapy Market Share by Regions (2015-2020)
Table 12. Global T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global T-Cell Immunotherapy Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. T-Cell Immunotherapy Market Growth Strategy
Table 18. Main Points Interviewed from Key T-Cell Immunotherapy Players
Table 19. Global T-Cell Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 20. Global T-Cell Immunotherapy Market Share by Players (2015-2020)
Table 21. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2019)
Table 22. Global T-Cell Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players T-Cell Immunotherapy Product Solution and Service
Table 25. Date of Enter into T-Cell Immunotherapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 28. Global T-Cell Immunotherapy Market Size Share by Type (2015-2020)
Table 29. Global T-Cell Immunotherapy Revenue Market Share by Type (2021-2026)
Table 30. Global T-Cell Immunotherapy Market Size Share by Application (2015-2020)
Table 31. Global T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 32. Global T-Cell Immunotherapy Market Size Share by Application (2021-2026)
Table 33. North America Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 34. North America Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 35. North America T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 36. North America T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 37. North America T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 38. North America T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 39. Europe Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 41. Europe T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 42. Europe T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 43. Europe T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 44. Europe T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 45. China Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 46. China Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 47. China T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 48. China T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 49. China T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 50. China T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 51. Japan Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 53. Japan T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 54. Japan T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 55. Japan T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 56. Japan T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 59. Southeast Asia T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 61. Southeast Asia T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 63. India Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 64. India Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 65. India T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 66. India T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 67. India T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 68. India T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 69. Central & South America Key Players T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players T-Cell Immunotherapy Market Share (2019-2020)
Table 71. Central & South America T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 73. Central & South America T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 75. Adaptimmune Company Details
Table 76. Adaptimmune Business Overview
Table 77. Adaptimmune Product
Table 78. Adaptimmune Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 79. Adaptimmune Recent Development
Table 80. Altor Bioscience Corporation Company Details
Table 81. Altor Bioscience Corporation Business Overview
Table 82. Altor Bioscience Corporation Product
Table 83. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 84. Altor Bioscience Corporation Recent Development
Table 85. Cellectis Company Details
Table 86. Cellectis Business Overview
Table 87. Cellectis Product
Table 88. Cellectis Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 89. Cellectis Recent Development
Table 90. Juno Therapeutics Company Details
Table 91. Juno Therapeutics Business Overview
Table 92. Juno Therapeutics Product
Table 93. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 94. Juno Therapeutics Recent Development
Table 95. Kite Pharma Company Details
Table 96. Kite Pharma Business Overview
Table 97. Kite Pharma Product
Table 98. Kite Pharma Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 99. Kite Pharma Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Product
Table 103. Novartis Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 104. Novartis Recent Development
Table 105. Takara Bio Company Details
Table 106. Takara Bio Business Overview
Table 107. Takara Bio Product
Table 108. Takara Bio Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 109. Takara Bio Recent Development
Table 110. Unum Therapeutics Business Overview
Table 111. Unum Therapeutics Product
Table 112. Unum Therapeutics Company Details
Table 113. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 114. Unum Therapeutics Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. CAR-T Features
Figure 3. TCR Features
Figure 4. TIL Therapies Features
Figure 5. Global T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
Figure 6. Stomach Cancer Case Studies
Figure 7. Lung Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Esophagus Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. T-Cell Immunotherapy Report Years Considered
Figure 13. Global T-Cell Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global T-Cell Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 15. Global T-Cell Immunotherapy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global T-Cell Immunotherapy Market Share by Players in 2019
Figure 18. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Immunotherapy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2019
Figure 20. North America T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 29. Altor Bioscience Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 31. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 33. Juno Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 35. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 37. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 39. Takara Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 41. Unum Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs